AssayIndex
Reports by quarter

Reports submitted in 2026-Q2 · page 8

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →

1,126 records29 pagesmedian on this page 98.97 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042844SurvodutideGGPepsGGPE-2512-Y2660Janoshik2026-Q298.414.02—Supplier-supplied2MARGINAL
AX-2026-042810RetatrutideGGPepsGGPE-2512-D2133Medutest2026-Q298.744.05—Buyer-sourced0PASS
AX-2026-042750IGF-1 LR3GGPepsGGPE-2604-K9879Janoshik2026-Q298.141.98—Buyer-sourced0PASS
AX-2026-042538BPC-157HJHJ-2511-P5900PeptideMeter2026-Q299.883.1393.5Buyer-sourced0PASS
AX-2026-042467EpitalonHomopeptideHOMO-2512-A5108Janoshik2026-Q299.937.81—Buyer-sourced0FAIL
AX-2026-042051RetatrutideHYBHYB-2604-D6658Nordanalyt2026-Q298.683.94—Buyer-sourced0PASS
AX-2026-041955SermorelinAMBAMB-2512-V5420Janoshik2026-Q299.103.17—Buyer-sourced0PASS
AX-2026-041920MazdutideSinoPepSNP-2602-U4281Janoshik2026-Q297.774.4188.7Buyer-sourced2MARGINAL
AX-2026-041906ARA-290SinoPepSNP-2605-G4075Medutest2026-Q298.945.28—Buyer-sourced0PASS
AX-2026-041884SemaglutideSinoPepSNP-2511-P4283PeptideMeter2026-Q298.044.1099.4Laboratory-retained0PASS
AX-2026-041748CagrilintideTFSTFS-{CAT}-1681Janoshik2026-Q299.414.49107.2Buyer-sourced0PASS
AX-2026-041660TirzepatideFGPFGP-2605-R8870Janoshik2026-Q297.916.52—Laboratory-retained0PASS
AX-2026-041368SemaglutideWWBWWB-2512-T3671Medutest2026-Q299.072.2996.5Buyer-sourced0PASS
AX-2026-041268SemaglutideWWBWWB-2603-W2120Janoshik2026-Q299.633.48—Buyer-sourced1MARGINAL
AX-2026-041266SemaglutideWWBWWB-2603-W2120VendorInvestigate2026-Q299.774.10—Buyer-sourced1MARGINAL
AX-2026-043573PEG-MGFSIGSIG-2602-6794Janoshik2026-Q298.584.79104.2Buyer-sourced0PASS
AX-2026-043505SemaxSIGSIG-2602-5969Medutest2026-Q298.968.6390.1Buyer-sourced0PASS
AX-2026-043311TB-500CPCCPC-2605-B1397Janoshik2026-Q298.235.5291.6Buyer-sourced0FAIL
AX-2026-043100HexarelinKPKP-2604-X5990Janoshik2026-Q298.823.5792.0Buyer-sourced0FAIL
AX-2026-043099HexarelinKPKP-2604-X5990Kestrel2026-Q298.583.49106.5Buyer-sourced0FAIL
AX-2026-042809RetatrutideGGPepsGGPE-2512-D2133Janoshik2026-Q298.183.90106.3Buyer-sourced0PASS
AX-2026-042754IGF-1 LR3GGPepsGGPE-2604-K9879VendorInvestigate2026-Q298.472.57—Buyer-sourced0PASS
AX-2026-042647MK-677 (Ibutamoren mesylate)SWBSWB-2605-B7365Nordanalyt2026-Q299.282.8693.1Buyer-sourced0FAIL
AX-2026-042027SS-31 (Elamipretide)HYBHYB-2512-B6579PeptideMeter2026-Q299.531.8489.8Buyer-sourced1MARGINAL
AX-2026-041686SemaglutideTFSTFS-{CAT}-9744PeptideMeter2026-Q298.216.58—Buyer-sourced0PASS
AX-2026-041363TirzepatideWWBWWB-2604-T3876Janoshik2026-Q298.983.9097.9Buyer-sourced0PASS
AX-2026-041211NAD+WWBWWB-2601-V1583Janoshik2026-Q299.7210.9493.5Buyer-sourced0FAIL
AX-2026-043518TirzepatideSIGSIG-2603-6158Janoshik2026-Q298.380.80103.2Buyer-sourced0PASS
AX-2026-043415SemaglutideWXTWXT-2512-F3324Kestrel2026-Q299.865.02—Buyer-sourced0PASS
AX-2026-043239SLU-PP-332SGNSGN-2602-X9377VendorInvestigate2026-Q298.285.37—Buyer-sourced0PASS
AX-2026-042954SemaxMKMMKM-2512-B3991VendorInvestigate2026-Q298.476.74—Buyer-sourced1FAIL
AX-2026-042875TB-500GGPepsGGPE-2601-B2671Nordanalyt2026-Q299.574.05—Buyer-sourced0PASS
AX-2026-042728TirzepatideGGPepsGGPE-2604-H1052Janoshik2026-Q299.341.6198.3Buyer-sourced0PASS
AX-2026-042575L-Glutathione (reduced)HJHJ-2511-F6153Janoshik2026-Q299.667.21—Buyer-sourced0PASS
AX-2026-042227MOTS-cTFCTFC-2605-R9506Kestrel2026-Q299.375.7796.0Buyer-sourced0PASS
AX-2026-042054TirzepatideHYBHYB-2512-W7237PeptideMeter2026-Q299.005.61100.1Buyer-sourced0PASS
AX-2026-042036SemaglutideHYBHYB-2511-F6451Janoshik2026-Q298.591.58—Buyer-sourced0PASS
AX-2026-041665PT-141 (Bremelanotide)FGPFGP-2602-Y8741Nordanalyt2026-Q299.513.8991.3Buyer-sourced0PASS
AX-2026-041246GHK-CuWWBWWB-2512-B1996Janoshik2026-Q299.735.58—Buyer-sourced1MARGINAL
AX-2026-043382MOTS-cWXTWXT-2511-P3368Medutest2026-Q299.415.21—Supplier-supplied1MARGINAL